AVELOX® (moxifloxacin hydrochloride) Tablets

AVELOX® I.V. (moxifloxacin hydrochloride in sodium chloride injection)

Prescribing Information

Medication Guide

  To view PDF documents, you must have Adobe Reader installed on your computer.





WARNING
Fluoroquinolones, including AVELOX, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants.

Fluoroquinolones, including AVELOX, may exacerbate muscle weakness in persons with myasthenia gravis. Avoid AVELOX in patients with known history of myasthenia gravis.




AVELOX is a registered trademark of Bayer Aktiengesellschaft and is used under license by Schering Corporation, a subsidiary of Merck & Co., Inc.


AINF 1015801-0000 11/11

Copyright © 2011 Schering Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
Terms and Conditions | Privacy Policy